| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 17.48▼ | 17.80▼ |
| MA10 | N/A | N/A | N/A | 17.60▼ | 18.24▼ |
| MA20 | N/A | N/A | N/A | 18.41▼ | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | 48.180▼ | N/A |
| STOCH | N/A | N/A | N/A | 14.653▼ | N/A |
| WILL %R | N/A | N/A | N/A | -90.642▼ | N/A |
| CCI | N/A | N/A | N/A | -52.890 | N/A |
|
Thursday, August 13, 2020 10:17 PM
NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics ...
|
|
Monday, July 01, 2019 01:31 PM
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/10/21 | 17.458 | 17.458 | 17.458 | 17.458 | 100 |
| 13/10/21 | 17.436 | 17.436 | 17.422 | 17.422 | 200 |
| 05/10/21 | 17.49 | 17.49 | 17.49 | 17.49 | 153 |
| 04/10/21 | 17.34 | 17.34 | 17.262 | 17.2756 | 224 |
| 01/10/21 | 17.25 | 17.7429 | 17.25 | 17.7429 | 170 |
| 30/09/21 | 17.5611 | 17.5611 | 17.5611 | 17.5611 | 1 |
| 24/09/21 | 18.89 | 18.89 | 18.89 | 18.89 | 155 |
| 21/09/21 | 17.695 | 17.695 | 17.695 | 17.695 | 100 |
| 15/09/21 | 17.21 | 17.21 | 17.21 | 17.21 | 1,000 |
| 14/09/21 | 17.93 | 17.93 | 17.302 | 17.302 | 596 |
|
|
||||
|
|
||||
|
|